Cargando…
First 1.5 years of pegvaliase clinic: Experiences and outcomes
We present Boston Children's Hospital's clinic model for pegvaliase therapy in adults with phenylketonuria (PKU) and clinical outcomes in 46 patients over the first 1.5 years of commercial therapy. Approximately 70% (18/26) of patients starting pegvaliase achieved blood phenylalanine (Phe)...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256053/ https://www.ncbi.nlm.nih.gov/pubmed/32489881 http://dx.doi.org/10.1016/j.ymgmr.2020.100603 |
_version_ | 1783539836756426752 |
---|---|
author | Sacharow, Stephanie Papaleo, Cassandra Almeida, Kyla Goodlett, Benjamin Kritzer, Amy Levy, Harvey Martell, Leslie Wessel, Ann Viau, Krista |
author_facet | Sacharow, Stephanie Papaleo, Cassandra Almeida, Kyla Goodlett, Benjamin Kritzer, Amy Levy, Harvey Martell, Leslie Wessel, Ann Viau, Krista |
author_sort | Sacharow, Stephanie |
collection | PubMed |
description | We present Boston Children's Hospital's clinic model for pegvaliase therapy in adults with phenylketonuria (PKU) and clinical outcomes in 46 patients over the first 1.5 years of commercial therapy. Approximately 70% (18/26) of patients starting pegvaliase achieved blood phenylalanine (Phe) <360 μmol/L, with an average of a 68 ± 24% decrease in blood Phe from baseline. All patients experienced at least minor side effects, but in most, management of the side effects allowed for treatment to continue. |
format | Online Article Text |
id | pubmed-7256053 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-72560532020-06-01 First 1.5 years of pegvaliase clinic: Experiences and outcomes Sacharow, Stephanie Papaleo, Cassandra Almeida, Kyla Goodlett, Benjamin Kritzer, Amy Levy, Harvey Martell, Leslie Wessel, Ann Viau, Krista Mol Genet Metab Rep Short Communication We present Boston Children's Hospital's clinic model for pegvaliase therapy in adults with phenylketonuria (PKU) and clinical outcomes in 46 patients over the first 1.5 years of commercial therapy. Approximately 70% (18/26) of patients starting pegvaliase achieved blood phenylalanine (Phe) <360 μmol/L, with an average of a 68 ± 24% decrease in blood Phe from baseline. All patients experienced at least minor side effects, but in most, management of the side effects allowed for treatment to continue. Elsevier 2020-05-25 /pmc/articles/PMC7256053/ /pubmed/32489881 http://dx.doi.org/10.1016/j.ymgmr.2020.100603 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Short Communication Sacharow, Stephanie Papaleo, Cassandra Almeida, Kyla Goodlett, Benjamin Kritzer, Amy Levy, Harvey Martell, Leslie Wessel, Ann Viau, Krista First 1.5 years of pegvaliase clinic: Experiences and outcomes |
title | First 1.5 years of pegvaliase clinic: Experiences and outcomes |
title_full | First 1.5 years of pegvaliase clinic: Experiences and outcomes |
title_fullStr | First 1.5 years of pegvaliase clinic: Experiences and outcomes |
title_full_unstemmed | First 1.5 years of pegvaliase clinic: Experiences and outcomes |
title_short | First 1.5 years of pegvaliase clinic: Experiences and outcomes |
title_sort | first 1.5 years of pegvaliase clinic: experiences and outcomes |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256053/ https://www.ncbi.nlm.nih.gov/pubmed/32489881 http://dx.doi.org/10.1016/j.ymgmr.2020.100603 |
work_keys_str_mv | AT sacharowstephanie first15yearsofpegvaliaseclinicexperiencesandoutcomes AT papaleocassandra first15yearsofpegvaliaseclinicexperiencesandoutcomes AT almeidakyla first15yearsofpegvaliaseclinicexperiencesandoutcomes AT goodlettbenjamin first15yearsofpegvaliaseclinicexperiencesandoutcomes AT kritzeramy first15yearsofpegvaliaseclinicexperiencesandoutcomes AT levyharvey first15yearsofpegvaliaseclinicexperiencesandoutcomes AT martellleslie first15yearsofpegvaliaseclinicexperiencesandoutcomes AT wesselann first15yearsofpegvaliaseclinicexperiencesandoutcomes AT viaukrista first15yearsofpegvaliaseclinicexperiencesandoutcomes |